Nonmotor disabilities in patients with facial palsy measured by patient-reported outcome measures

Volk, Gerd Fabian; Granitzka, Thordis; Kreysa, Helene; Klingner, Carsten M.; Guntinas‐Lichius, Orlando

doi:10.1002/lary.25695

Cited by 36 publications

(29 citation statements)

References 30 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…It is well documented that general questionnaires such as those on the SF-36 have low sensitivity to facial palsy. 44,51 We believe that we have replicated such findings through our use of the FDI; facial nerve function does not seem to impact general questions on QOL assessments. Interestingly, however, the social/well-being evaluation of the symptom-specific FDI questionnaire demonstrated that the MS cohort had results similar to those of the healthy controls despite the reduced HB grade of the former group.…”

Section: Discussionsupporting

confidence: 53%

“…2,26,49 Some of these studies have compared general quality of life (QOL) following treatment-but it is well known that general QOL inventories such as the 36-Item Short Form Health Survey (SF-36) are less sensitive to facial nerve weakness. 44,51 Microsurgery (MS) provides a high cure rate when a tumor is completely removed and remains, according to some authors, the preferred treatment modality for small-and medium-sized VSs, especially in younger patients. 25,29,53,56 Given improvements in microsurgical techniques over the past several decades and the introduction of intraoperative electrophysiological monitoring of the facial nerve, the incidence of facial nerve injury associated with VS microsurgery has declined significantly.…”

mentioning

confidence: 99%

See 1 more Smart Citation

Patient- versus physician-reported facial disability in vestibular schwannoma: an international cross-sectional study

Tveiten

Carlson

Goplen

et al. 2017

Journal of Neurosurgery

View full text Add to dashboard Cite

OBJECTIVE Patient-reported outcomes are increasingly used in studies of vestibular schwannoma (VS); however, few studies have examined self-evaluated facial nerve function and its relation to physician-reported outcomes. The primary objective of this study was to compare patient self-evaluations of facial disability with physician-evaluated facial nerve status and with self-evaluations of a healthy control group. The second objective was to provide insight into the controversial subject of the optimal initial management of small- and medium-sized VSs; consequently, the authors compared patient-reported facial nerve disability following treatment via observation (OBS), Gamma Knife surgery (GKS), or microsurgery (MS). Lastly, the authors sought to identify risk factors for facial nerve dysfunction following treatment for small- and medium-sized VSs. METHODS All patients with a VS 3 cm or smaller that was singly treated with OBS, GKS, or MS at either of 2 independent treatment centers between 1998 and 2008 were retrospectively identified. Longitudinal facial nerve measures and clinical data, including facial nerve evaluation according to the House-Brackmann (HB) grading system, were extracted from existing VS databases. Supplementing the objective data were Facial Disability Index (FDI) scores, which were obtained via survey of patients a mean of 7.7 years after initial treatment. RESULTS The response rate among the 682 eligible patients was 79%; thus, data from a total of 539 patients were analyzed. One hundred forty-eight patients had been managed by OBS, 247 with GKS, and 144 with MS. Patients who underwent microsurgery had larger tumors and were younger than those who underwent OBS or GKS. Overall, facial nerve outcomes were satisfactory following treatment, with more than 90% of patients having HB Grade I function at the last clinical follow-up. Treatment was the major risk factor for facial nerve dysfunction. Almost one-fifth of the patients treated with MS had an objective decline in facial nerve function, whereas only 2% in the GKS group and 0% in the OBS cohort had a decline. The physical subscale of the FDI in the VS patients was highly associated with HB grade; however, the social/well-being subscale of the FDI was not. Thus, any social disability caused by facial palsy was not detectable by use of this questionnaire. CONCLUSIONS The majority of patients with small- and medium-sized VSs attain excellent long-term facial nerve function and low facial nerve disability regardless of treatment modality. Tumor size and microsurgical treatment are risk factors for facial nerve dysfunction and self-reported disability. The FDI questionnaire is sensitive to the physical but not the social impairment associated with facial dysfunction.

show abstract

Section: Discussionsupporting

confidence: 53%

mentioning

confidence: 99%

Patient- versus physician-reported facial disability in vestibular schwannoma: an international cross-sectional study

Tveiten

Carlson

Goplen

et al. 2017

Journal of Neurosurgery

View full text Add to dashboard Cite

show abstract

“…It can be a devastating and disfiguring condition, leading to psychological difficulties and restrictions of facial expressions, and may have a dramatic impact on interpersonal relationships. 1 The impact of FP on quality of life (QoL) is well known, [2][3][4][5][6][7][8][9][10][11][12][13][14][15][16][17][18][19] although sometimes no correlation has been found between severity of FP and QoL. [3][4][5][6]8,20 When it has been found, the correlation ranges from 0.13 to 0.66, 2,10,12,14,15,17,21,22 meaning that other factors may be important contributors to QoL in patients with FP.…”

Section: Introductionmentioning

confidence: 99%

Facial Palsy‐Specific Quality of Life in 920 Patients: Correlation With Clinician‐Graded Severity and Predicting Factors

et al. 2018

View full text Add to dashboard Cite

show abstract

“…The clinician's overall impression of the patient is taken as standard and is assumed to represent the degree of abnormality of facial function [1, 2, 4-6, 8, 26-36]. This enables clinicians to keep track of patients' recovery and evaluate the efficacy of treatment [4,28,31,37]. FNP is assessed using grading scales that typically measure patients' facial function, grade symmetry of the face at rest, and measure displacement of facial features during voluntary movement, as well as the presence of synkinesis.…”

Section: Introductionmentioning

confidence: 99%

Face-to-Face Versus Video Assessment of Facial Paralysis: Implications for Telemedicine (Preprint)

Tan¹,

Coulson²,

Keep³

2018

Preprint

View full text Add to dashboard Cite

show abstract

Nonmotor disabilities in patients with facial palsy measured by patient-reported outcome measures

Abstract: 4. Laryngoscope, 126:1516-1523, 2016.

Cited by 36 publications

References 30 publications

Patient- versus physician-reported facial disability in vestibular schwannoma: an international cross-sectional study

Patient- versus physician-reported facial disability in vestibular schwannoma: an international cross-sectional study

Facial Palsy‐Specific Quality of Life in 920 Patients: Correlation With Clinician‐Graded Severity and Predicting Factors

Face-to-Face Versus Video Assessment of Facial Paralysis: Implications for Telemedicine (Preprint)

Contact Info

Product

Resources

About